*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
A Pure Tablet for Stabilization Indication Of RP-HPLC Techniques by Estimating Pitavastatin And Ezetimible Solutions

Author: SRAVANATHI P, MUTHU BABU K, DR RAVIKUMAR RAJU, DR TEJA
Abstract: This paper proposes the Hyperlipidemia is one of the clinical conditions mainly associated with coronary heart disease. Use of Statins in combination with Ezetimibe proven to give better results in treatment of said conditions. The current work aims to progress a simple accurate and sensitive stability indicating technique for estimation of Pitavastatin and Ezetimibe in pharmaceutical dosage form.The separation was achieved by using X-Bridge Phenyl (150×3.5µ, 4.6mm) column with a mobile phase containing of 0.1% Formic acid and Methanol (30:70). The separation was monitored for 8min at 250nm using 1ml/min flow rate. The established technique authenticated as per ICH Q2 (R1) rules. The technique was linear over a absorption rangeof 1 to 15ppm and 5 to 75ppmfor Pitavastatin and Ezetimibe respectively and correlation coefficient isoriginate to be 0.999 for the drugs.HPLC technique developed for approximation of selected drugs in pure and have shown satisfactory, accurate and reproducible results (without any interference of recipients) as well, it is inferred that the modest and petite projected methods be greatest valuable for investigation resolution. The present work concluded that stability indicating assay method by RP-HPLC was simple, accurate, precise, and specific and has no interference with the placebo and degradation products. Hence these are utilized for regular examination of Pitavastatin and Ezetimibe.
Keyword: Hyperlipidemia, Pitavastatin, Ezetimibe, RP-HPLC, Stability Indicating
DOI: https://doi.org/10.31838/ijpr/2020.SP2.428
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free